No significant differences were determined between male and female CHF patients in terms of NYHA functional class, BMI, hs-CRP, eGFR, hyperuricemia, hypertension, type 2 diabetes mellitus, atrial fibrillation, or SDS score. This evidence concerns the gene CRP and atrial fibrillation.